Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Alpha Emitter market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.4% during the forecast period.
This report presents the market size and development trends by detailing the Alpha Emitter market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Alpha Emitter market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Alpha Emitter industry and will help you to build a panoramic view of the industrial development.
Alpha Emitter Market, By Type:
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi -213)
Alpha Emitter Market, By Application:
Glioma
Melanoma
Pancreatic Cancer
Ovarian Cancer
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Other
Some of the leading players are as follows:
Telix Pharmaceuticals
Alpha Tau Medical
Actinium Pharmaceutical Inc.
IBA Radiopharma Solutions
Fusion Pharmaceuticals Ltd
Orano Med Ltd
Cellectar Biosciences Inc.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Alpha Emitter Market: Technology Type Analysis
-
4.1 Alpha Emitter Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Alpha Emitter Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Terbium (Tb-149)
4.3.2 Astatine (At-211)
4.3.3 Bismuth (Bi-212)
4.3.4 Actinium (Ac-225)
4.3.5 Radium (Ra-223)
4.3.6 Lead (Pb-212)
4.3.7 Bismuth (Bi -213)
5 Alpha Emitter Market: Product Analysis
-
5.1 Alpha Emitter Product Market Share Analysis, 2018 & 2026
-
5.2 Alpha Emitter Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Alpha Emitter Market: Application Analysis
-
6.1 Alpha Emitter Application Market Share Analysis, 2018 & 2026
-
6.2 Alpha Emitter Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Glioma
6.3.2 Melanoma
6.3.3 Pancreatic Cancer
6.3.4 Ovarian Cancer
6.3.5 Thyroid
6.3.6 Bone Metastasis
6.3.7 Lymphoma
6.3.8 Endocrine Tumors
6.3.9 Other
7 Alpha Emitter Market: Regional Analysis
-
7.1 Alpha Emitter Regional Market Share Analysis, 2018 & 2026
-
7.2 Alpha Emitter Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Telix Pharmaceuticals
9.1.1 Telix Pharmaceuticals Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Alpha Tau Medical
9.2.1 Alpha Tau Medical Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Actinium Pharmaceutical Inc.
9.3.1 Actinium Pharmaceutical Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 IBA Radiopharma Solutions
9.4.1 IBA Radiopharma Solutions Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Fusion Pharmaceuticals Ltd
9.5.1 Fusion Pharmaceuticals Ltd Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Orano Med Ltd
9.6.1 Orano Med Ltd Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Cellectar Biosciences Inc.
9.7.1 Cellectar Biosciences Inc. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
The List of Tables and Figures (Totals 93 Figures and 131 Tables)
Figure Terbium (Tb-149) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Astatine (At-211) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Bismuth (Bi-212) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Actinium (Ac-225) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Radium (Ra-223) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Lead (Pb-212) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Bismuth (Bi -213) Alpha Emitter market, 2015 - 2026 (USD Million)
Figure Glioma market, 2015 - 2026 (USD Million)
Figure Melanoma market, 2015 - 2026 (USD Million)
Figure Pancreatic Cancer market, 2015 - 2026 (USD Million)
Figure Ovarian Cancer market, 2015 - 2026 (USD Million)
Figure Thyroid market, 2015 - 2026 (USD Million)
Figure Bone Metastasis market, 2015 - 2026 (USD Million)
Figure Lymphoma market, 2015 - 2026 (USD Million)
Figure Endocrine Tumors market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Alpha Emitter market, by country, 2015 - 2026 (USD Million)
-
Table North America Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table North America Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table North America Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Canada Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Canada Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Europe Alpha Emitter market, by country, 2015 - 2026 (USD Million)
-
Table Europe Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Europe Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Europe Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Germany Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Germany Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table France Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table France Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Italy Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Italy Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Spain Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Spain Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Alpha Emitter market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table China Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table China Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Japan Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Japan Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table India Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table India Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Alpha Emitter market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table MEA Alpha Emitter market, by country, 2015 - 2026 (USD Million)
-
Table MEA Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table MEA Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table MEA Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Alpha Emitter market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Alpha Emitter market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Alpha Emitter market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Telix Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alpha Tau Medical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Actinium Pharmaceutical Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IBA Radiopharma Solutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Fusion Pharmaceuticals Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Orano Med Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cellectar Biosciences Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
